Its campaign arms patients with questions to ask their doctors before they're prescribed an opioid.
Like other sectors, pharma is experiencing upheavals no one predicted, and as a result, drugs are being reviled for their price tags, rather than praised for their value.
Actor Patrick Dempsey is helping patients get over the pressure of scheduling an appointment
Walmart and Humana have started acquisition talks; Blue Cross and Blue Shield says opioids should not be the first treatment option to manage pain
As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts sayFebruary 01, 2018
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'
Forget making incremental changes to the system. These three corporate giants are trying to change the model of U.S. healthcare itself.
Quick facts on the groundbreaking healthcare announcement made Tuesday morning by the three blue chip companies.
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate
Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.
AstraZeneca sales fall on generic competition; Anthem broadens access for Duchenne muscular dystrophy drug; researchers are developing new biopsy techniques
The health insurance startup launched a campaign this week that urges people to get covered.
Consumers younger than the age of 45 were most likely to use an app developed by their health plan.
Insurance companies balk at expensive PCSK9 inhibitors; Publicis to focus investments on AI platform; clinical trial reveals Novartis' eye drug requires less frequent injections
A study published in Health Affairs detailed an outcomes-based pilot developed by the drugmaker and Priority Health, a Michigan-based health insurer.
Nobody knows what the future holds for the Affordable Care Act under the Trump administration and an emboldened Republican Congress.
Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia
Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in
When drug costs started to soar, PBMs turned to formulary exclusions — and the industry is still feeling the pinch.
The pull-back of insurance providers has left state-run health exchanges and the Obama administration facing a difficult communications challenge.
OncoGenex's prostate cancer drug fails in clinical trial; Aetna to exit exchanges in 11 states; pregnant women taking acetaminophen have higher risks for their children
A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion
The campaign will run in an integrated digital marketing format using channels such as Facebook, Twitter, and Youtube.